Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HALT NUCs: Halting Nucleoside Analogue Therapy in Chronic Hepatitis B

NCT04102176 is registered in ClinicalTrials.gov with Seng Gee Lim as lead sponsor.

NCT NCT04102176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HALT NUCs: Halting Nucleoside Analogue Therapy in Chronic Hepatitis B
Lead sponsor
Seng Gee Lim
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 29, 2019
Completion date
February 28, 2026
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b